Arthur He
Stock Analyst at HC Wainwright & Co.
(3.58)
# 825
Out of 5,131 analysts
48
Total ratings
58.82%
Success rate
27.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Maintains: Buy | $135 → $165 | $71.33 | +131.32% | 6 | Feb 10, 2026 | |
| JBIO Jade Biosciences | Initiates: Buy | $25 | $15.03 | +66.33% | 1 | Jan 7, 2026 | |
| VERA Vera Therapeutics | Maintains: Buy | $85 → $90 | $42.22 | +113.17% | 3 | Nov 10, 2025 | |
| ADAG Adagene | Maintains: Buy | $8 → $7 | $3.25 | +115.38% | 11 | Aug 15, 2025 | |
| AUPH Aurinia Pharmaceuticals | Assumes: Buy | $17 | $14.23 | +19.47% | 1 | Jul 30, 2025 | |
| SLDB Solid Biosciences | Reiterates: Buy | $20 | $6.19 | +223.10% | 10 | Jun 17, 2025 | |
| PRME Prime Medicine | Downgrades: Neutral | n/a | $3.30 | - | 8 | May 20, 2025 | |
| BCAB BioAtla | Reiterates: Neutral | n/a | $0.15 | - | 8 | Mar 31, 2025 |
Nektar Therapeutics
Feb 10, 2026
Maintains: Buy
Price Target: $135 → $165
Current: $71.33
Upside: +131.32%
Jade Biosciences
Jan 7, 2026
Initiates: Buy
Price Target: $25
Current: $15.03
Upside: +66.33%
Vera Therapeutics
Nov 10, 2025
Maintains: Buy
Price Target: $85 → $90
Current: $42.22
Upside: +113.17%
Adagene
Aug 15, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.25
Upside: +115.38%
Aurinia Pharmaceuticals
Jul 30, 2025
Assumes: Buy
Price Target: $17
Current: $14.23
Upside: +19.47%
Solid Biosciences
Jun 17, 2025
Reiterates: Buy
Price Target: $20
Current: $6.19
Upside: +223.10%
Prime Medicine
May 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $3.30
Upside: -
BioAtla
Mar 31, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.15
Upside: -